Results 251 to 260 of about 17,262,511 (380)

Screening for lung cancer: A systematic review of overdiagnosis and its implications

Molecular Oncology, EarlyView.
Low‐dose computed tomography (CT) screening for lung cancer may increase overdiagnosis compared to no screening, though the risk is likely low versus chest X‐ray. Our review of 8 trials (84 660 participants) shows added costs. Further research with strict adherence to modern nodule management strategies may help determine the extent to which ...
Fiorella Karina Fernández‐Sáenz, Laura de la Torre‐Perez, David R Baldwin, Carlijn van der Aalst, Mangesh Thorat, David Ritchie, Andre L Carvalho, Carolina Espina, Ivan Solà, Carlos Canelo‐Aybar, Moira Magdalena Pissinis, Pablo Alonso‐Coello, Ana Carolina Pereira Nunes Pinto   +12 more
wiley   +1 more source

Predictive factors for clinical outcome of palliative ventriculoperitoneal shunt in the treatment of leptomeningeal metastasis. [PDF]

Transl Cancer Res
Min L, Zhang N, Zhang Q, Zheng M, Zhu Y.
europepmc   +1 more source

220. Chemotherapy in Combination with T-Cell Therapy Results in Significant Antitumor Activity and Improved Clinical Outcomes for EBV-Associated Nasopharyngeal Carcinoma [PDF]

, 2011

openalex   +1 more source

Clinical presentation, etiology, and outcome of infective endocarditis in the 21st century: the International Collaboration on Endocarditis-Prospective Cohort Study.

Archives of Internal Medicine, 2009
D. Murdoch, G. Corey, B. Hoen, J. Miró, V. Fowler, A. Bayer, A. Karchmer, L. Olaison, P. Pappas, P. Moreillon, S. Chambers, V. Chu, V. Falcó, D. Holland, P. Jones, J. Klein, N. Raymond, K. Read, M. Tripodi, R. Utili, Andrew Wang, C. Woods, C. Cabell   +22 more
semanticscholar   +1 more source

Glycosylated LGALS3BP is highly secreted by bladder cancer cells and represents a novel urinary disease biomarker

Molecular Oncology, EarlyView.
Urinary LGALS3BP is elevated in bladder cancer patients compared to healthy controls as detected by the 1959 antibody–based ELISA. The antibody shows enhanced reactivity to the high‐mannose glycosylated variant secreted by cancer cells treated with kifunensine (KIF).
Asia Pece, Giulio Lovato, Ilaria Cela, Arianna Mercatelli, Benedetta Ferro, Jussi Nikkola, Sara Pagotto, Tommaso Grottola, Vincenzo De Laurenzi, Rossella Cicchetti, Antonio Marchetti, Luigi Schips, Rossano Lattanzio, Stefano Iacobelli, Emily Capone, Peter Black, Mads Daugaard, Michele Marchioni, Gianluca Sala   +18 more
wiley   +1 more source

Defining score interpretation thresholds for clinical outcome assessments: a review of terminology and reporting recommendations. [PDF]

J Patient Rep Outcomes
Flood E, Clarke N, King-Kallimanis BL, Musoro J, Eremenco S, Ward CL, Cappelleri JC, Nolte S.   +7 more
europepmc   +1 more source

Clinical Research (Observations, Pathophysiology & Outcomes) [PDF]

Journal of Investigative Dermatology, 2015
openaire   +2 more sources

Evaluation of the site score in primary pyogenic spinal infections: Correlation with clinical and radiological outcomes

Jonathan Neuhoff, Andreas Krämer, Santhosh G. Thavarajasingam, Benjamin M. Davies, Frank Kandziora, F. Ringel, Andreas K. Demetriades, Ehab Shiban   +7 more
openalex   +1 more source

Use of Real-World Evidence to Characterize Clinical Outcomes in Patients Who Develop Acute Graft Versus Host Disease Undergoing Allogeneic Stem Cell Transplantation in the United States [PDF]

, 2018
Mona Akbari, Jennifer Drahos, Barbara H. Johnson, Gilwan Kim, Jiao Yang, Aliki Taylor   +5 more
openalex   +1 more source

Survivin and Aurora Kinase A control cell fate decisions during mitosis

Molecular Oncology, EarlyView.
Aurora A interacts with survivin during mitosis and regulates its centromeric role. Loss of Aurora A activity mislocalises survivin, the CPC and BubR1, leading to disruption of the spindle checkpoint and triggering premature mitotic exit, which we refer to as ‘mitotic slippage’.
Hana Abdelkabir, Shalitha Wickrama Arachchige, Sally P. Wheatley   +2 more
wiley   +1 more source